Showing results (51-60 of 1,291) with videos related to
Sort By:
Pageof 130
Biostatistics (Oxford, England)|September 2, 2022
Cross-direct effects in settings with two mediatorsErin E Gabriel, Arvid Sjölander, Dean Follmann, et al.Biometrika|March 24, 2015
Estimation of mean response via effective balancing scoreZonghui Hu, Dean A Follmann, Naisyin WangStatistics in Medicine|February 4, 2015
Vaccine design via nonnegative lasso-based variable selectionZonghui Hu, Dean A Follmann, Kazutoyo MiuraClinical and Vaccine Immunology : CVI|June 20, 2014
Matched longitudinal analysis of biomarkers associated with survivalLori E Dodd, Reed F Johnson, Joseph E Blaney, et al.Transfusion|June 27, 2002
Kinetics of G-CSF-induced granulocyte mobilization in healthy subjects: effects of route of administration and addition of dexamethasoneDavid F Stroncek, Cynthia L Matthews, Dean Follmann, et al.Arthritis and Rheumatism|December 8, 2011
A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitisMichael C Sneller, Zonghui Hu, Carol A LangfordBiometrics|September 14, 2015
New methods for treatment effect calibration, with applications to non-inferiority trialsZhiwei Zhang, Lei Nie, Guoxing Soon, et al.BMC Genetics|February 21, 2004
A statistical method for adjusting covariates in linkage analysis with sib pairsColin O Wu, Gang Zheng, Eric Leifer, et al.The Journal of Infectious Diseases|December 4, 2012
Enhanced effector function of CD8(+) T cells from healthy controls and HIV-infected patients occurs through thrombin activation of protease-activated receptor 1Amanda Hurley, Mindy Smith, Tatiana Karpova, et al.The Journal of Infectious Diseases|February 18, 2011
High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trialAnuradha Ganesan, Nancy Crum-Cianflone, Jeanette Higgins, et al.Pageof 130